Literature DB >> 16844542

Treatment of erectile dysfunction with chronic dosing of tadalafil.

Chris G McMahon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16844542     DOI： 10.1016/j.eururo.2006.03.018

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  4 in total

1.  Endothelial nitric oxide synthase keeps erection regulatory function balance in the penis.

Authors:  Trinity J Bivalacqua; Tongyun Liu; Biljana Musicki; Hunter C Champion; Arthur L Burnett
Journal:  Eur Urol       Date:  2006-11-10       Impact factor: 20.096

2.  Open-label, Intermittent Dose, Prospective Study Evaluating the Effects of Tadalafil on Lower Urinary Tract Symptoms and Erectile Function in Patients with Benign Prostatic Hyperplasia: Continuation and Durability of Effects.

Authors:  Tae-Beom Kim; Khae-Hawn Kim; Sang-Jin Yoon
Journal:  Int Neurourol J       Date:  2010-04-30       Impact factor: 2.835

3.  Comparison of the efficacy and safety of 5-mg once-daily versus 5-mg alternate-day tadalafil in men with erectile dysfunction and lower urinary tract symptoms.

Authors:  H Choi; J-H Kim; J-S Shim; J Y Park; S H Kang; D G Moon; J Cheon; J G Lee; J J Kim; J-H Bae
Journal:  Int J Impot Res       Date:  2014-07-03       Impact factor: 2.896

4.  Chronic low dosing of phosphodiesterase type 5 inhibitor for erectile dysfunction.

Authors:  Hyun Hwan Sung; Sung Won Lee
Journal:  Korean J Urol       Date:  2012-06-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.